RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES
Impact
The proposed legislation is expected to significantly impact state laws related to health insurance coverage and diabetes care management. By removing financial barriers associated with procuring glucagon, the bill aims to ensure that individuals with diabetes can more effectively manage their condition and prevent emergencies resulting from low blood sugar levels. Supporters argue that this will lead to better health outcomes and potentially reduce the overall costs associated with diabetes-related health emergencies. The state assembly acknowledges that swift access to glucagon can be the difference between life and death in critical situations, supporting this expansion in coverage as a necessary public health measure.
Summary
Senate Bill S2112 aims to improve the accessibility of glucagon auto-injectors by requiring all health insurance plans that offer prescription benefits to cover at least one type of glucagon formulation that does not require reconstitution. This coverage is mandated to begin on January 1, 2027. The bill stipulates that individuals covered under such health plans would not face any copayment or deductible for obtaining up to two glucagon auto-injectors within a single plan year. This initiative is driven by the recognition of glucagon's critical role as a life-saving medication for individuals experiencing severe hypoglycemia, a common risk associated with diabetes management.
Contention
While the bill has received support for promising improved health outcomes, it may also face some contention regarding its implications for health insurance economics. Questions may arise concerning the financial impact on insurance providers who are now required to expand their coverage without co-pays or deductibles. Some industry stakeholders fear that this requirement could result in increased premiums or constraints on other types of covered services. Balance between accessibility and financial sustainability will likely be a central topic of debate as the bill progresses through the legislative process.
Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.
Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.
Requires at fault insurance companies to provide to any claimant whose vehicle is damaged in an accident, to provide a vehicle that is comparable to the claimant’s vehicle and that rental charges shall be based on local retail prices.
Requires at fault insurance companies to provide to any claimant whose vehicle is damaged in an accident, to provide a vehicle that is comparable to the claimant’s vehicle and that rental charges shall be based on local retail prices.
Makes numerous technical corrections related to insurance, provides a definition for "cybersecurity insurance", and would repeal the chapter relating to reciprocal exchanges and interinsurers.
Makes numerous technical corrections related to insurance, provides a definition for "cybersecurity insurance", and would repeal the chapter relating to reciprocal exchanges and interinsurers.
Removes the age restriction for benefits coverage and requires, for health insurance policies issued or renewed on or after January 1, 2026, that coverage must include reimbursement for applied behavior analysis provider services.